Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application).
Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Prof. Javed Ali passed his BPharm and MPharm with distinction from Jamia Hamdard and bagged gold medals in 1994 and 1996, respectively. He earned a PhD in the year 2000. He was a postdoctoral fellow at the Institute of Pharmaceutical Technology, University of Frankfurt, Germany in 2005. He has a total experience of 25 years in teaching and research. Presently, he is working as a professor at the Department of Pharmaceutics, School of Pharmaceutical Education and Research, and is in-charge of IP Management Cell, Jamia Hamdard, New Delhi.
Prof. Ali has been bestowed with several honors; a few of them worth mentioning include the Career Award for Young Teachers by All India Council of Technical Education (2003); APTI-Young Pharmacy Teacher of the year (2004) by Association of Pharmacy Teachers of India; the BOYSCAST Fellowship of Department of Science and Technology, Government of India (2005); American Association of Indian Pharmaceutical Scientists (AAiPS)-IPA Distinguished Educator and Researcher Award 2007 at the Association meeting at San Diego, United States; Research Award 2014 by University Grants Commission, New Delhi; and Indian National Science Academy (INSA) Teachers Award 2018 by INSA, New Delhi for his outstanding teaching methodology and research outputs; in addition, several awards for best paper presentations at conferences of Indian Pharmaceutical Congress, Indian Pharmacy Graduate Association, and Controlled Release Society, Indian Chapter. He has also received certificates of recognition for publications in high-impact factor journals from Jamia Hamdard.Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 44013331
Quantité disponible : 1 disponible(s)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In English. N° de réf. du vendeur ria9780128222119_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 44013331-n
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 44013331
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 44013331-n
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Kartoniert / Broschiert. Etat : New. Updated reference on drug approval processes in key global markets Provides comprehensive coverage of concepts and regulatory affairs Presents a concise compilation of the regulatory requirements of different countries In. N° de réf. du vendeur 494817189
Quantité disponible : Plus de 20 disponibles
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. N° de réf. du vendeur CbS 9780128222119
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Neuware - Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. N° de réf. du vendeur 9780128222119
Quantité disponible : 2 disponible(s)